Aurobindo Pharma Limited (APL), one of the worlds top ... In the year 1998, the company had launched new formulations like auronim Suspension in the paediatric segment. During 1999-2000, the ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as investors responded positively to strong Q4 results and favourable FY26 outlook ...

Axis Securities maintains a 'buy' on Aurobindo Pharma and Lupin, expecting strong performance in the pharmaceutical sector, ...

Shares of Aurobindo Pharma Ltd fell 2.5 percent to Rs 1,161 in morning trade on May 28 after the company reported an 11 percent increase in revenue and a marginal drop in net profit in the March ...

Aurobindo Pharma Ltd (BOM:524804) reports robust financial performance with significant growth in European and specialty segments, despite challenges in key markets.

Aurobindo Pharma's stock experienced a price fall during today's trading session. The stock is currently trading at Rs 1,167.10, reflecting a decrease of 2.02%. This movement places Aurobindo ...

Aurobindo Pharma posted a marginal decrease in its net profit at ₹903 crore in the fourth quarter ended March 31, 2025, compared with ₹907 crore in the corresponding quarter of the previous ...

Generic drugmaker Aurobindo Pharma reported consolidated net profit for the March quarter declined marginally to ₹903 crore compared with ₹907 crore a year earlier. The lower net profit came ...

Generic drugmaker Aurobindo Pharma, through wholly owned subsidiary Apitoria on Friday, announced the launch of a six-month post-graduation certification in leadership (CLP) programme at the ...

On the stocks to buy front, Sachin Gupta recommends Aurobindo Pharma Ltd, and Bharat Dynamics Ltd. Here's what Gupta says about the stock market. Nifty 50 rose by 0.5% today, driven primarily by ...

Aurobindo Pharma (ARBP) is actively investing across multiple high-potential segments to drive sustained growth over the next 3-5 years. The company’s Penicillin G (PEN-G) project is scaling up ...

Shares rose over 3% following brokerage upgrade Motilal Oswal changed rating to Buy with ₹1,360 target Stock down 25% from recent high of ₹1,592 Shares of Aurobindo Pharma rose over 3% on ...